David Park '19, Author at Dartmouth Business Journal

When Two and Two Come Together: Personalization in Business Models

At the Dartmouth Entrepreneurs Forum on April 1, 2016, dozens of students, aspiring entrepreneurs and interested individuals attended informative workshops and sought out the advice of esteemed speakers. Among the speakers were Amanda Reed, a general partner at Palomar Ventures,... Continue reading...

Markets

Sustained Growth and R&D: The Pharmaceutical Industry’s Divide

Nearly two years since AstraZeneca shafted Pfizer’s $104-billion courtship offer, Pfizer and Allergan announced on Nov. 23, 2015 that they were going to merge with a $160-billion mega-deal – the largest deal in the pharmaceutical industry’s history. After the deal... Continue reading...

Government

The Pharmaceutical Price Gouging Dilemma

Drugs play a critical role in our daily lives – they can be used to reduce pain, regulate bodily processes, and even mitigate metastasizing of cancer. Since pharmaceutical drugs are essential to the health of American citizens, the public reacts... Continue reading...

Dartmouth Business Journal

When Two and Two Come Together: Personalization in Business Models

Sustained Growth and R&D: The Pharmaceutical Industry’s Divide

The Pharmaceutical Price Gouging Dilemma

Popular

Foreign Direct Investment in Nigeria

Singapore’s Market-Model Healthcare System

The Smartwatch – the Next “It” Item?

Cutco: Schemers or Success Story?

Fast Food Goes Global

The Korean Wave That Has Engulfed the World

Random

When Two and Two Come Together: Personalization in Business Models

Pharmaceutical Giants & Biotech Firms: Happily Ever After?

Abandoning the Federal Funds Rate

Horizontal Disruption and Private Equity Dominance Will Drive 2019 TMT M&A

Will Head Injuries Impact the Future of Professional High-Contact Spots?

Progress Short of Postcards